SEC Form 4/A · accession 0001177648-18-000037
ENANTA PHARMACEUTICALS INC · ENTA
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
This is an amendment (Form 4/A). It replaces an earlier filing for the same period.
Reporting owner
Tim Ocain
Officer — Senior Vice President
Period of report
Jan 30, 2014
Accepted (ET)
Oct 2, 2018 · 4:21 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001177648
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (right to buy)F1,F2 | $32.27 | Jan 30, 2014 | A | 70,000 | A | — | Jan 30, 2024 | Common Stock | 70,000 | 70,000 | D |
Explanation of responses
- F1This amendment is being filed to correct the original Form 4 filing by amending the conversion or exercise price of the derivative security reported in column 2 from "$32.43" to "$32.27". This amendment corrects an administrative error.
- F225% of the shares subject to the option will vest on the first anniversary of January 30, 2014 (the "Commencement Date"), and the remaining shares will vest in twelve (12) successive and equal quarterly installments thereafter, such that 100% of the shares subject to the option will be fully vested and exercisable on the fourth anniversary of the Commencement Date.